Buy Cyient Ltd For Target Rs. 910 - ICICI Direct
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/10/3a0c9602d4f0201986c69b16a5c81e2c.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Aiming at US$1 bn revenues in FY24
About the stock: Cyient Ltd (Cyient) offers engineering & development services to aerospace & defence, transportation, E&U, communication and others.
* Cyient has 300 customers across 14 countries
* Net debt free and healthy cash flow with OCF/EBITDA ~80%
Q2FY23 Results: Cyient reported acquisition led strong Q2 results.
* Services revenue grew 12.3% QoQ in CC terms & group revenue grew 10% QoQ in CC terms
* Normalised services EBIT margin without acquisitions came in at 13.2%, up by ~110 bps QoQ
* Won five large deals with total contract potential of US$ 105.2 million (mn)
What should investors do: Cyient’s share price has grown by ~1.5x over the past five years (from ~| 517 in October 2017 to ~| 765 levels in October 2022).
* We maintain our BUY rating on the stock
Target Price and Valuation: We value Cyient at | 910 i.e. 14x P/E on FY25E EPS
Key triggers for future price performance:
* Acquired entities to provide diversification, which, in turn, is expected to provide growth, looking at US$1 bn revenues in FY24
* Improved demand from large deals, healthy order book, rebound in DLM business and organisation restructuring to accelerate growth
* Strategic buyout a multi-year arrangement with an auto major
Alternate Stock Idea: Apart from Cyient, in our IT coverage we also like Infosys.
* Strong revenue guidance prompts us to be positive
* BUY with a target price of | 1,670
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
SEBI Registration number is INZ000183631
Above views are of the author and not of the website kindly read disclaimer
![](https://portfolio.investmentguruindia.com/uploads/news/Ipca Laboratories Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/narendramode37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Muthoot Finance ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/hiroshiyoshida.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Skills Revolution1231.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/cummins.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/investment37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Tata Steel Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Tarun Chugh, MD & CEO, Bajaj Allianz Life.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/car37.jpg)